Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Bock

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Journal of Biological Standardization|October 1, 1989
Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccineU Klockmann, H L Bock, V Franke, et al.
Journal of Medical Virology|May 1, 1995
Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual menG Hess, R Clemens, U Bienzle, et al.
Archives of Internal Medicine|October 28, 1996
Immunogenicity of a recombinant hepatitis B vaccine in adultsH L Bock, J Kruppenbacher, R Sänger, et al.
British Journal of Haematology|May 1, 1994
Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathwayR Clemens, C Pramoolsinsap, R Lorenz, et al.
Vaccine|April 6, 2006
A short report on clinical evaluation of RIX4414: highlights of world-wide developmentB De Vos, A Delem, K Hardt, et al.
Singapore Medical Journal|September 18, 2010
Influenza and seasonal influenza vaccination among diabetics in Singapore: knowledge, attitudes and practicesE K Tan, L H Lim, Y L Teoh, et al.
Lancet (London, England)|November 18, 1995
Pertussis in adults: frequency of transmission after household exposureC H Wirsing von König, S Postels-Multani, H L Bock, et al.
Vaccine|February 1, 1990
A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response studyH L Bock, U Klockmann, C Jüngst, et al.
Vaccine|January 1, 1991
Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunizationU Klockmann, H L Bock, H Kwasny, et al.
Vaccine|March 1, 1997
Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillanceR Clemens, R Sänger, J Kruppenbacher, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Journal of Biological Standardization|October 1, 1989
Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccineU Klockmann, H L Bock, V Franke, et al.
Journal of Medical Virology|May 1, 1995
Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual menG Hess, R Clemens, U Bienzle, et al.
Archives of Internal Medicine|October 28, 1996
Immunogenicity of a recombinant hepatitis B vaccine in adultsH L Bock, J Kruppenbacher, R Sänger, et al.
British Journal of Haematology|May 1, 1994
Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathwayR Clemens, C Pramoolsinsap, R Lorenz, et al.
Vaccine|April 6, 2006
A short report on clinical evaluation of RIX4414: highlights of world-wide developmentB De Vos, A Delem, K Hardt, et al.
Singapore Medical Journal|September 18, 2010
Influenza and seasonal influenza vaccination among diabetics in Singapore: knowledge, attitudes and practicesE K Tan, L H Lim, Y L Teoh, et al.
Lancet (London, England)|November 18, 1995
Pertussis in adults: frequency of transmission after household exposureC H Wirsing von König, S Postels-Multani, H L Bock, et al.
Vaccine|February 1, 1990
A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response studyH L Bock, U Klockmann, C Jüngst, et al.
Vaccine|January 1, 1991
Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunizationU Klockmann, H L Bock, H Kwasny, et al.
Vaccine|March 1, 1997
Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillanceR Clemens, R Sänger, J Kruppenbacher, et al.
Pageof 7